Use of Traditional and Proteomic Methods in the Assessment of a Preclinical Model of Preeclampsia
Drug Metabolism and Disposition · 2023
DOI: 10.1124/dmd.122.001080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2023. Verfasst von Wanying Dai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Placenta, Pre-Eclampsia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: CIHR.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
- Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada m.piquette.miller@utoronto.ca.
Förderung
- CIHR
Zitieren
APA
Dai, W., Pollinzi, A., & Piquette-Miller, M. (2023). Use of Traditional and Proteomic Methods in the Assessment of a Preclinical Model of Preeclampsia. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.122.001080
Vancouver
Dai W, Pollinzi A, Piquette-Miller M. Use of Traditional and Proteomic Methods in the Assessment of a Preclinical Model of Preeclampsia. Drug Metabolism and Disposition. 2023. doi:10.1124/dmd.122.001080
BibTeX
@article{Dai2023,
author = {Dai, Wanying and Pollinzi, Angela and Piquette-Miller, Micheline},
title = {Use of Traditional and Proteomic Methods in the Assessment of a Preclinical Model of Preeclampsia},
journal = {Drug Metabolism and Disposition},
year = {2023},
doi = {10.1124/dmd.122.001080}
}
EUVIMED